AmplioSpeech Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • AmplioSpeech's estimated annual revenue is currently $7.5M per year.(i)
  • AmplioSpeech's estimated revenue per employee is $47,771

Employee Data

  • AmplioSpeech has 157 Employees.(i)
  • AmplioSpeech grew their employee count by 13% last year.

AmplioSpeech's People

NameTitleEmail/Phone
1
Speech Language PathologistReveal Email/Phone
2
Speech Language PathologistReveal Email/Phone
3
Human Resources CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M15713%N/AN/A
Add Company

What Is AmplioSpeech?

At AmplioSpeech we understand Speech-Language Disorders, and are dedicated to addressing the challenges presented to children who are impacted by these issues. AmplioSpeech delivers innovative speech-language therapy, that optimizes clinical outcomes with the power of: award-winning technologies, revolutionary service delivery model and a community of qualified speech-language pathologists. 12% of the total population suffer from speech impediments - language delay, articulation, voice, fluency, aphasia autistic spectrum disorders. AmplioSpeech is on its way to revolutionize speech-language therapy, we provide schools with tomorrow's technology to help children today!

keywords:N/A

N/A

Total Funding

157

Number of Employees

$7.5M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AmplioSpeech News

2022-02-22 - He just wanted to help his son, and now his startup lands $27M

Led by Dr. Yair Shapira, Israeli startup AmplioSpeech uses AI to help connect children with learning disabilities with their teachers and...

2022-02-22 - AmplioSpeech raises $27 million for special education platform | Ctech

AmplioSpeech offers an outcomes-driven, intuitive digital platform that engages students, and partners with special education professionals to...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.6M1571%N/A
#2
$46.6M1576%N/A
#3
N/A16124%N/A
#4
$17.8M1628%N/A
#5
$31.6M16444%N/A